{"id":"https://openalex.org/A5120894261","orcid":"https://orcid.org/0009-0001-3216-7409","observed_orcids":["https://orcid.org/0009-0001-3216-7409"],"display_name":"Ruchi Srivastava","raw_author_names":["Ruchi Srivastava","Srivastava, Ruchi"],"full_name":"Ruchi Srivastava","works_count":3,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":0.6666666666666666,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5120894261","orcid":"https://orcid.org/0009-0001-3216-7409","observed_orcids":["https://orcid.org/0009-0001-3216-7409"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210103923","ror":"https://ror.org/01e70kg07","display_name":"Munger University","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210103923"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210103923","ror":"https://ror.org/01e70kg07","display_name":"Munger University","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210103923"]}],"topics":[{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","count":2,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","count":2,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":1,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":1,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10798","display_name":"Crystallography and molecular interactions","count":1,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","value":1.38e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":9.9e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":2.8e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":2.5e-06,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10464","display_name":"Crystal structures of chemical compounds","value":1.3e-06,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9861999750137329},{"id":"41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","score":0.7052000164985657},{"id":"71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","score":0.574999988079071},{"id":"21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","score":0.5166000127792358},{"id":"178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","score":0.3605000078678131}],"counts_by_year":[{"year":2025,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2026,"works_count":2,"oa_works_count":1,"cited_by_count":2}],"display_name_alternatives":["Ruchi Srivastava","Srivastava, Ruchi"],"block_key":"r srivastava","works_api_url":"https://api.openalex.org/works?filter=author.id:A5120894261","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2025-12-21T00:00:00"}